For instance, recent studies reported the therapeutic efficacy of two CRISPR systems delivered by viral vectors, SpCas9 and dCas9-KRAB, in mouse models of NSCLC with KRAS G12S mutation [112, 113]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.